The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1

Virology Journal

Volumn 10, Issue , 2013, Pages

  Huang, Yujing ^a   Qi, Ying ^a   Ma, Yanping ^a   He, Rong ^a   Ji, Yaohua ^a   Sun, Zhengrong ^a   Ruan, Qiang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

HCMV infection; hcmv miR UL112 1; IL 32

Indexed keywords

HUMAN CYTOMEGALOVIRUS MICRORNA UL112 1; IMMUNOGLOBULIN M; INTERLEUKIN 32; MESSENGER RNA; MICRORNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BLOOD SAMPLING; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LUNG FIBROBLAST; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; WESTERN BLOTTING;

HUMAN HERPESVIRUS 5;

EID: 84873699387     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-51     Document Type: Article

References (40)

1. IL-32, a novel cytokine with a possible role in disease. Dinarello CA, Kim SH, Ann Rheum Dis 2006 65 ii61 iii64 10.1136/ard.2006.058511 17038476 (Pubitemid 44629106)
2. Interleukin-32: a cytokine and inducer of TNFalpha. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA, Immunity 2005 22 131 142 15664165
3. IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. Bai X, Kim SH, Azam T, McGibney MT, Huang H, Dinarello CA, Chan ED, J Immunol 2010 184 7 3830 3840 10.4049/jimmunol.0901913 20190143
4. Inflammation-dependent secretion and splicing of IL-32 gamma in rheumatoid arthritis. Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LA, Proc Natl Acad Sci USA 2011 108 12 4962 4967 10.1073/pnas.1016005108 21383200
5. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB, Proc Natl Acad Sci USA 2006 103 9 3298 3303 10.1073/pnas.0511233103 16492735 (Pubitemid 43346464)
6. Interleukin-32 positively regulates radiation-induced vascular inflammation. Kobayashi H, Yazlovitskaya EM, Lin PC, Int J Radiat Oncol Biol Phys 2009 74 5 1573 1579 10.1016/j.ijrobp.2009.04.017 19616744
7. IL-32: an emerging player in the immune response network against tuberculosis? Kundu M, Basu J, PLoS Med 2006 3 8 274 10.1371/journal.pmed. 0030274 16903776 (Pubitemid 44338350)
8. Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. Netea M, Azam GT, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, Kim SH, Dinarello CA, PLoS Med 2006 3 8 277 10.1371/journal.pmed.0030277 16903774 (Pubitemid 44338369)
9. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A, Clin Exp Immunol 2007 149 3 480 486 10.1111/j.1365-2249.2007.03439.x 17590175 (Pubitemid 47256156)
10. Interleukin-32α expression in human colonic subepithelial myofibroblasts. Yagi Y, Andoh A, Imaeda H, Aomatsu T, Ohsaki R, Inatomi O, Bamba S, Tsujikawa T, Shimizu T, Fujiyama Y, Int J Mol Med 2011 27 2 263 268 21152864
11. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. Kim YG, Lee CK, Oh JS, Kim SH, Kim KA, Yoo B, Arthritis Rheum 2010 62 2 515 523 20112365
12. Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. Mabilleau G, Sabokbar A, PLoS One 2009 4 1 4173 10.1371/journal. pone.0004173 19137064
13. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST, Gao Y, Kang L, Hao Q, Peng G, Chen Y, Chen X, Wu J, Zhu Y, PLoS One 2008 3 4 1985 10.1371/journal.pone.0001985 18414668 (Pubitemid 352003402)
14. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Li W, Yang F, Liu Y, Gong R, Liu L, Feng Y, Hu P, Sun W, Hao Q, Kang L, Wu J, Zhu Y, Eur J Immunol 2009 39 4 1019 1024 10.1002/eji.200838885 19291698
15. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, Fang J, Zhang W, Wu J, Zhu Y, J Immunol 2010 185 9 5056 5065 10.4049/jimmunol.0902667 20889550
16. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB. Pan X, Cao H, Lu J, Shu X, Xiong X, Hong X, Xu Q, Zhu H, Li G, Shen G, Mol Immunol 2011 48 12-13 1573 1577 21481941
17. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Moschen AR, Fritz T, Clouston AD, Rebhan I, Bauhofer O, Barrie HD, Powell EE, Kim SH, Dinarello CA, Bartenschlager R, Jonsson JR, Tilg H, Hepatology 2011 53 6 1819 1829 10.1002/hep.24285 21381070
18. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Lee S, Kim JH, Kim H, Kang JW, Kim SH, Yang Y, Kim J, Park J, Park S, Hong J, Yoon DY, Immunology 2011 132 3 410 420 10.1111/j.1365-2567.2010.03377.x 21208204
19. Endogenous IL-32 controls cytokine and HIV-1 production. Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, Dinarello CA, J Immunol 2008 181 1 557 565 18566422
20. Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Rasool ST, Tang H, Wu J, Li W, Mukhtar MM, Zhang J, Mu Y, Xing HX, Wu J, Zhu Y, Immunol Lett 2008 117 2 161 167 10.1016/j.imlet. 2008.01.007 18329725
21. The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection. Smith AJ, Toledo CM, Wietgrefe SW, Duan L, Schacker TW, Reilly CS, Haase AT, J Immunol 2011 186 11 6576 6584 10.4049/jimmunol.1100277 21525393
22. Cytomegaloviruses. Mocarski ES, Shenk T, Pass RF, Fields Virology Lippincott, Williams & Wilkins, Philadelphia, PA, Knipe DM, Howley PM, 5 2007 2701 2773
23. Cytomegalovirus in hematopoietic stem cell transplant ecipients: current status, known challenges, and future strategies. Boeckh M, Zaia J, Biol Blood Marrow Transplant 2003 9 543 558 10.1016/S1083-8791(03)00287-8 14506657 (Pubitemid 38351787)
24. Cytomegalovirus infection following stem cell transplantation. Einsele H, Hebart H, Haematologica 1999 84 Suppl. EHA-4 46 49 10907466
25. The functions of animal microRNAs. Ambros V, Nature 2003 431 50 355
26. RNAi: the nuts and bolts of the RISC machine. Filipowicz W, Cell 2005 122 17 20 10.1016/j.cell.2005.06.023 16009129 (Pubitemid 40977936)
27. Identification of microRNAs of the herpesvirus family. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grässer FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T, Nat Methods 2005 2 4 269 276 10.1038/nmeth746 15782219 (Pubitemid 41131008)
28. Human cytomegalovirus expresses novel microRNAs during productive viral infection. Dunn W, Trang P, Zhong Q, Yang E, van Belle C, Liu F, Cell Microbiol 2005 7 11 1684 1695 10.1111/j.1462-5822.2005.00598.x 16207254 (Pubitemid 41511924)
29. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. Grey F, Meyers H, White EA, Spector DH, Nelson J, PLoS Pathog 2007 3 11 163 10.1371/journal.ppat.0030163 17983268 (Pubitemid 350291597)
30. Host immune system gene targeting by a viral miRNA. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, Goldman-Wohl D, Greenfield C, Yagel S, Hengel H, Altuvia Y, Margalit H, Mandelboim O, Science 2007 317 5836 376 381 10.1126/science.1140956 17641203 (Pubitemid 47106378)
31. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: Implications for latency. Murphy E, Jiří V, Thomas S, Arnold JL, Proc Natl Acad Sci USA 2008 105 14 5453 5458 10.1073/pnas.0711910105 18378902 (Pubitemid 351753884)
32. Analysis of human cytomegalovirus-encoded microRNA activity during infection. Stern-Ginossar N, Saleh N, Goldberg MD, Prichard M, Wolf DG, Mandelboim O, J Virol 2009 83 20 10684 10693 10.1128/JVI.01292-09 19656885
33. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5′UTRs. Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L, Nelson JA, PLoS Pathog 2010 6 6 1000967 10.1371/journal.ppat.1000967 20585629
34. Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Kim S, Lee S, Shin J, Kim Y, Evnouchidou I, Kim D, Kim YK, Kim YE, Ahn JH, Riddell SR, Stratikos E, Kim VN, Ahn K, Nat Immunol 2011 12 10 984 991 10.1038/ni.2097 21892175
35. BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Lee SH, Kalejta RF, Kerry J, Semmes OJ, O'Connor CM, Khan Z, Garcia BA, Shenk T, Murphy E, Proc Natl Acad Sci USA 2012 109 24 9575 9580 10.1073/pnas.1207496109 22645331
36. A rapid method to screen putative mRNA targets of any known microRNA. Huang Y, Qi Y, Ruan Q, Ma Y, He R, Ji YH, Sun ZR, Virol J 2011 8 8 10.1186/1743-422X-8-8 21219658
37. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G, Nature 2000 403 901 906 10.1038/35002607 10706289 (Pubitemid 30130993)
38. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Brennecke J, Hipfner DR, Stark A, Russel RB, Cohen SM, Cell 2003 113 25 36 10.1016/S0092-8674(03)00231-9 12679032 (Pubitemid 36411957)
39. Numerous microRNPs in neuronal cells containing novel microRNAs. Dostie J, Mourelatos Z, Yang M, Sharma A, Dreyfuss G, RNA 2003 9 180 186 10.1261/rna.2141503 12554860 (Pubitemid 36206286)
40. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Xu P, Vernooy SY, Guo M, Hay BA, Curr Biol 2003 13 790 795 10.1016/S0960-9822(03)00250-1 12725740 (Pubitemid 36531030)